BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6897690)

  • 1. [Effect of various cytostatics and radiotherapy on serum iron and copper levels in lymphoma patients].
    Georgieva B; Gekova K; Arsov Ts
    Vutr Boles; 1982; 21(6):91-6. PubMed ID: 6897690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of iron and total iron binding capacity in the serum of patients with lymphoreticular blastomas].
    Gekova K; Georgieva B
    Vutr Boles; 1974; 13(6):100-4. PubMed ID: 4619515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum iron and serum copper in patients with lymphogranulomatosis].
    Anders O; Klemm HJ; Bendel L; Konrad H
    Z Gesamte Inn Med; 1984 Apr; 39(8):169-72. PubMed ID: 6730594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood protein, iron and copper, and leukocyte alkaline phosphatase in lymphoma].
    Martinetto P; Neretto G; Agricola R; Pellerito R; Giovanelli E; Fassio D
    Arch Sci Med (Torino); 1980; 137(1):119-26. PubMed ID: 7458644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors.
    Caballero MD; Rubio V; Rifon J; Heras I; García-Sanz R; Vázquez L; Vidriales B; del Cañizo MC; Corral M; Gonzalez M; León A; Jean-Paul E; Rocha E; Moraleda JM; San Miguel JF
    Bone Marrow Transplant; 1997 Sep; 20(6):451-8. PubMed ID: 9313877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum copper assay as a biochemical marker to assess the response to therapy in Hodgkin's disease.
    Kesava Rao KV; Shetty PA; Bapat CV; Jussawalla DJ
    Indian J Cancer; 1977 Dec; 14(4):320-4. PubMed ID: 612553
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of iron supplementation and discontinuation on serum copper, zinc, calcium, and magnesium levels in women.
    Newhouse IJ; Clement DB; Lai C
    Med Sci Sports Exerc; 1993 May; 25(5):562-71. PubMed ID: 8492683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of serum parameters of iron metabolism and of the natural resistance of tuberculosis patients under treatment].
    Vasile DI; Stoinescu M; Corlan E; Zaharescu C; Dumitrescu M; Paunescu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1980; 29(4):221-7. PubMed ID: 6270774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Iron, copper and zinc content in healthy persons and iron-deficiency anemia patients].
    Mikhaĭlova L; Keon E; Raĭkova K
    Vutr Boles; 1981; 20(6):114-21. PubMed ID: 7336702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma].
    Tura S; Bernardi L; Baccarani M; Sanguinetti F; Branzi A
    G Clin Med; 1968 Nov; 49(11):1090-104. PubMed ID: 5757473
    [No Abstract]   [Full Text] [Related]  

  • 11. [Total serum copper in histiocyte sarcomatosis with a systemic tendency].
    Papa G; de Laurenzi A; Amadori S
    Haematologica; 1972; 57(3):179-83. PubMed ID: 4625059
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reduced glutathione and porphobilinogen synthase activity in the erythrocytes of anemic patients with low serum iron].
    Gekova K; Arsov Ts; Georgieva B
    Vutr Boles; 1982; 21(4):84-7. PubMed ID: 7147924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Aurlien E; Holte H; Pharo A; Kvaløy S; Jakobsen E; Smeland EB; Kvalheim G
    Bone Marrow Transplant; 1998 May; 21(9):873-8. PubMed ID: 9613778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in the treatment of malignant lymphoma].
    Ogura M
    Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiotherapy treatment of lymphoma].
    Juretić A; Zivković M; Samija M; Cović D; Bistrović M; Viculin T; Bagović D; Tomek R
    Lijec Vjesn; 2000; 122(11-12):283-91. PubMed ID: 11291272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma iron and copper in Hodgkin's disease. A comparison with other laboratory indicators.
    Gobbi PG; Scarpellini M; Minoia C; Pozzoli L; Perugini S
    Haematologica; 1979 Aug; 64(4):416-32. PubMed ID: 121577
    [No Abstract]   [Full Text] [Related]  

  • 17. Ceruloplasmin in Hodgkin's disease.
    Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
    Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.
    Moskowitz CH; Glassman JR; Wuest D; Maslak P; Reich L; Gucciardo A; Coady-Lyons N; Zelenetz AD; Nimer SD
    Clin Cancer Res; 1998 Feb; 4(2):311-6. PubMed ID: 9516916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood iron and blood copper in acute and chronic leukemia and in Hodgkin's disease].
    RECHENBERGER J
    Dtsch Z Verdau Stoffwechselkr; 1957 Apr; 17(2):78-85. PubMed ID: 13437842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.